tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KROS Stock Latest News

Keros Therapeutics Showcases Innovations at Major Conferences
Company AnnouncementsKeros Therapeutics Showcases Innovations at Major Conferences
14h ago
8K
KROS
Keros Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Keros Therapeutics Reports Q3 2024 Financial Results
5d ago
KROS
Keros Therapeutics reports Q3 EPS ($1.41), consensus ($1.28)
PremiumThe Fly
Keros Therapeutics reports Q3 EPS ($1.41), consensus ($1.28)
20d ago
KROS
Keros Therapeutics to Present at Guggenheim Conference
PremiumCompany Announcements
Keros Therapeutics to Present at Guggenheim Conference
21d ago
8K
KROS
Jefferies starts Keros with Buy, sees potential $2B in peak sales
PremiumThe Fly
Jefferies starts Keros with Buy, sees potential $2B in peak sales
21d ago
KROS
Keros Therapeutics initiated with a Buy at Jefferies
PremiumThe FlyKeros Therapeutics initiated with a Buy at Jefferies
21d ago
KROS
Keros Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Keros Therapeutics initiated with an Overweight at Cantor Fitzgerald
1M ago
KROS
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
Premium
The Fly
Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
1M ago
EL
AAP
Keros Therapeutics Appoints New Chief Medical Officer
PremiumCompany Announcements
Keros Therapeutics Appoints New Chief Medical Officer
1M ago
8K
KROS
Keros Therapeutics appoints Chyung as CMO
PremiumThe Fly
Keros Therapeutics appoints Chyung as CMO
1M ago
KROS
TRML
Keros Therapeutics initiated with an Outperform at Scotiabank
PremiumThe Fly
Keros Therapeutics initiated with an Outperform at Scotiabank
1M ago
KROS
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 9/23/2024, According to Top Analysts 
2M ago
SKX
GPCR
Keros Therapeutics initiated with a Buy at Guggenheim
PremiumThe FlyKeros Therapeutics initiated with a Buy at Guggenheim
2M ago
KROS
Keros Therapeutics price target lowered to $76 from $81 at BofA
Premium
The Fly
Keros Therapeutics price target lowered to $76 from $81 at BofA
3M ago
KROS
Keros Therapeutics closes screening for Phase 2 trial of cibotercept
Premium
The Fly
Keros Therapeutics closes screening for Phase 2 trial of cibotercept
3M ago
KROS
Keros Therapeutics CEO to Speak at Major Healthcare Conferences
PremiumCompany Announcements
Keros Therapeutics CEO to Speak at Major Healthcare Conferences
3M ago
8K
KROS
Keros Therapeutics director sells $11.0M in common stock
PremiumThe Fly
Keros Therapeutics director sells $11.0M in common stock
3M ago
KROS
Keros Therapeutics participates in a conference call with Cantor Fitzgerald
PremiumThe Fly
Keros Therapeutics participates in a conference call with Cantor Fitzgerald
3M ago
KROS
Keros Therapeutics Updates Investors with New Presentation
PremiumCompany Announcements
Keros Therapeutics Updates Investors with New Presentation
4M ago
8K
KROS
Keros Therapeutics reports Q2 EPS ($1.25), consensus ($1.23)
PremiumThe FlyKeros Therapeutics reports Q2 EPS ($1.25), consensus ($1.23)
4M ago
KROS
Keros Therapeutics initiated with an Outperform at Oppenheimer
Premium
The Fly
Keros Therapeutics initiated with an Outperform at Oppenheimer
5M ago
KROS
3 Best Stocks to Buy Now, 6/18/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 6/18/2024, According to Top Analysts 
5M ago
AVPT
HUMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >